Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders

Details for Australian Patent Application No. 2009221634 (hide)

Owner Grant, R. Braidy, N. Guillemin, G. Smythe, G.

Inventors Grant, Ross Stewart; Guillemin, Gilles; Smythe, George; Braidy, Nady

Agent Hodgkinson McInnes

Pub. Number AU-A-2009221634

PCT Pub. Number WO2009/108999

Priority 2008901036 03.03.08 AU

Filing date 3 March 2009

Wipo publication date 11 September 2009

International Classifications

A61K 31/05 (2006.01)

A61K 31/7084 (2006.01) - Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 39/04 (2006.01) General protective or antinoxious agents

A61P 39/06 (2006.01) General protective or antinoxious agents

Event Publications

14 October 2010 PCT application entered the National Phase

  PCT publication WO2009/108999 Priority application(s): WO2009/108999

16 June 2011 Assignment before Grant

  Guillemin, Giles; Grant, Ross; Braidy, Nady; Smythe, George The application has been assigned to NAD Life Pty Ltd

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009221638-Heat reflective laminate

2009221633-Tactile marker